Curcumin dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
Across 103 studies and 42 health measures, only four had high-certainty evidence, including CRP, a blood marker of swelling. Curcumin barely gets into the blood, so the results belong to special high-absorption forms, not to turmeric.
Evidence grade for Curcumin: Moderate. The rule: at least one finished study in people, and at least 100 people who took it. The sum on this page: 3 completed trials, 195 people given it. A grade counts how much has been done to people, not whether it works.
- People given it
- 195
- Human studies
- 3
- Found nothing
- 0
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
3 completed trials, 195 people given it
5 effects reported, 3 unwanted, 2 wanted, by people using it, not a trial
Goal pages: Ageing and longevity, Injury, healing and recovery, Heart and circulation, Immune system and inflammation, Bone and joints, Gut health
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
Curcumin is the yellow stuff in turmeric. People take pills of it for pain and swelling. The spice in food is not the same as the pill. The pills use special forms because plain curcumin barely gets into the blood. It is a supplement, not a drug.
What people take it for
- Less joint pain.
- Lower swelling numbers on a blood test.
- A longer life, because it is in a lot of ageing stacks.
What studies in people showed
People first. A 2024 review pooled 103 trials in 7216 people. Only four of 42 results were rated high certainty. Those four were fasting blood sugar, CRP, HDL and weight. CRP is a blood marker of inflammation. Across 66 trials, CRP fell 0.58 mg/L. A 100 person trial in people with metabolic syndrome used curcumin with black pepper extract, and blood fats moved. A 50 person knee trial used a better absorbed form and pain scores fell. A small 45 person study in rheumatoid arthritis, a joint disease, compared curcumin with a pain drug. Nobody has shown that moving those numbers prevents a heart attack. Turmeric root is only 2 to 5 percent curcuminoids. Food is not a trial dose. In mice, the US ageing mouse programme tested curcumin. Those mice did not live longer.
What people report
Reports, not study results
The good
- Some people say their knees feel better after a few weeks of a trial style pill.
- Stomach upset is usually the only complaint at normal pill doses.
The bad
- A lot of people feel nothing and stop.
- Cheap turmeric capsules are not the form the trials used.
- Rare liver injury has been reported with high dose high absorption products.
Where these come from: The trial counts and marker changes are from the reviews and trials on this page. The no effect and stomach reports are from supplement forums. Those are not from a trial.
My bottom line
It can move a blood marker. It did not make mice live longer. I would not take it to live longer.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Measured in people
Goals Curcumin has been tested for in people, biggest studies first. We count only what the studies on this page say, so the real numbers may be higher.
- Cholesterol and blood fats100 people · 1 study
- Joint and knee pain95 people · 2 studies
Animal and lab work, not yet tested in people
Real results, but from animals or cells, not people. What works in a mouse often does not work the same way in a person. Nobody can patent this, so nobody would ever earn back the cost of a study in people. That is usually why there is none. The record on this one is set out below.
- Living longer1 animal or lab study
32 of the 36 indexed goals have no study of any kind behind Curcumin
No study in people, animals or cells on this page reports a result for these. That does not prove Curcumin does nothing for them. It does mean anything you have heard about Curcumin and one of these did not come from a study cited here.
When this earns a spot
It earns a spot when hs-CRP is up and you are well, so the number is not just a cold. The form is the whole product. Powder is not the same as phytosome. It does not earn a spot because the JUPITER study used CRP to pick people for a statin.
Aaron's list, tier 2
Bloodwork that belongs beside the bottle
Repeat a high value before you buy the bottle.
Test again after about 90 days. If that blood number did not move, stop.
- Do not take your starting hs-CRP after a fever, a race, or dental work.
- Biotin can throw off some lab tests.
Reading the number
Many lab sheets call under 1 mg/L lower risk. Over 10 usually means you are sick right now. If ninety days of the same form did not move a steady hs-CRP, stop.
What these tests mean: hs-CRP.
What people typically order
Ask for hs-CRP on a day you feel well. The partners page is /bloodwork/partners. Bottle quality is covered at /supplements/quality.
Show full evidence
What is Curcumin?
Across 103 studies and 42 health measures, only four had high-certainty evidence, including CRP, a blood marker of swelling. Curcumin barely gets into the blood, so the results belong to special high-absorption forms, not to turmeric.
Curcumin has one of the largest sets of human studies of any plant compound. To read it, separate three things people mix up. Turmeric is the spice. Curcumin is the molecule inside it. And studies mostly use special forms built to absorb better.
A 2024 review pooled 103 studies in 7,216 people across 42 health measures. About 55% of the measures showed a real change. But the evidence was rated high certainty for only four: fasting blood sugar, CRP (a blood marker of swelling), HDL (good) cholesterol and weight. Everything else was rated moderate, low or very low. A separate review of 66 studies found CRP down 0.58 mg/L. Two other swelling markers, TNF-alpha and IL-6, also fell. A third, IL-1 beta, did not change.
So curcumin does lower swelling markers in the blood. These studies did not measure whether that changes how anyone's life goes.
How does Curcumin work?
Curcumin is a plant compound that sticks to a huge number of targets in a dish. That is part of its appeal. It is also a reason for caution, because things that stick to everything in a dish often do little in the body. Its best-backed actions: it turns down NF-kappa-B, a master switch for swelling signals, and it turns up Nrf2, which raises the body's own antioxidant defences. Its big problem is absorption. Plain curcumin barely gets in. The gut and liver change it fast, and the body clears it quickly. Every trick on the market exists to fix that: adding piperine from black pepper, binding it to fats (phytosomes), or shrinking it into tiny particles. Each one gives very different blood levels.
What have studies in people found about Curcumin?
A large set of human studies with steady effects on swelling and blood sugar markers. Only four of 42 measures had high-certainty evidence. No study has measured a hard health result like a heart attack or death.
- 103 studies, 7,216 people: high certainty for fasting blood sugar, CRP, HDL (good) cholesterol and weight. Everything else was moderate or worse.
- 66 studies pooled for swelling: CRP down 0.58 mg/L, TNF-alpha and IL-6 both down, IL-1 beta unchanged.
- A 100 person study in metabolic syndrome used curcumin plus piperine for 8 weeks. Blood fats improved.
- Knee arthritis is among the more positive uses. Effects are modest, and studies often compare it with a real drug rather than a dummy pill. A 50 person study of a high-absorption form (Theracurmin) found less knee pain at 8 weeks.
- A 45 person rheumatoid arthritis pilot compared curcumin with a pain drug. Everyone improved, and curcumin alone improved most.
- The mixed results cluster where absorption differs. That is what you would expect if the form sets how much gets in, and how much gets in sets the effect.
- At supplement doses it is mostly safe. Stomach upset is the usual complaint. Rare liver injury has been reported with high-dose, high-absorption products.
What this does not tell you: Two limits stand out. First, almost every result is a blood marker. Lowering CRP by 0.58 mg/L changes a number that predicts risk. No curcumin study has shown that lowering it this way prevents anything. Second, the evidence belongs to specific forms, not to the molecule. A study of a fat-bound (phytosome) form says little about a plain turmeric capsule. It says nothing about turmeric in food, which is only 2 to 5% curcuminoids. The 2024 reviewers themselves flag the quality of the studies they pooled as a weakness.
The state of the research
Curcumin is the clearest example in this section of real evidence attached to the wrong thing. A reader who sees 103 human studies fairly concludes that curcumin is well studied, and it is. What the number hides is that only four of 42 measures reached high certainty. It also hides that the studies used special forms built to fix an absorption problem that a spice jar does not fix.
That matters in practice. Say you take curcumin because your CRP is high. The studies back a form with proven absorption, at a study dose, with a CRP retest to tell you whether it worked for you. If you add turmeric powder to food for the same reason, you are doing something no study has tested.
One more fact comes from mice. The US National Institute on Aging runs the only lifespan testing programme in mice across several sites, using mice bred to be genetically mixed. Curcumin did not make those mice live longer, male or female. If you take it to live longer, you are going against the one careful lifespan test that exists. The swelling marker evidence in people is real, and it is a different claim.
The evidence, in charts
Fig. 1a · how many people
195people, across 3 studies in people cited here
| Study | People | Share |
|---|---|---|
| Complementary Therapies in Medicine 2014 | 100 | 51% |
| Journal of Orthopaedic Science 2014 | 50 | 26% |
| Phytotherapy Research 2012 | 45 | 23% |
One study holds 51% of these people, so the total rests more on one study than its size suggests. Counts are the number of people each study on this page says it signed up. That includes studies that only watched people and gave nobody the compound. Studies still signing people up are left out, and only studies cited on this page are counted.
Fig. 1b · evidence mix
3 of 7 sources here are studies in people. The rest are not.
- Study in people · done in people343%
- Animal study · done in animals114%
- Review of studies · sums up other studies343%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 5 different years, 2012 to 2024, counted from the list of sources on this page.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Supplement
- Molecule weight
- 368.4 Da. Turmeric root is roughly 2 to 5% curcuminoids, so the spice and the extract are not interchangeable doses.
- Half-life
- Stated in words, not a numbersee the exact wording below
- Chain length
- None on file
Half-life as stated on file: Very short for unformulated curcumin, with extensive first-pass conjugation and plasma concentrations often near the limit of detection after ordinary doses. Enhanced formulations report multi-fold increases in exposure, and those multiples are formulation-specific rather than a property of curcumin.
No amino acid sequence is on file for Curcumin, which is expected: a supplement is not built from amino acids.
The studies we cite
- Study in people2012A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis
A very small rheumatoid arthritis pilot put 45 people on curcumin, a pain drug (diclofenac), or both. Disease scores improved in all three groups, and the curcumin-only group improved most. 45 people split three ways cannot settle a long-term disease. Treat it as a reason to run a proper study, not as proof.
45 adults with active rheumatoid arthritis randomised to curcumin 500 mg, diclofenac 50 mg, or both. DAS28 and ACR scores improved in all three arms, with the largest percentage improvement on curcumin alone. Pilot size.
- Study in people2014Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial
A high-absorption mix of curcumin and piperine improved blood fats in people who already had metabolic syndrome. 100 people took 1000 mg a day of the mix, or a dummy pill, for 8 weeks on top of usual care. LDL, triglycerides and total cholesterol fell, and HDL rose. This tested one specific form on blood fats. It is not about turmeric in food, and it did not measure heart attacks.
100 adults with metabolic syndrome randomised to curcuminoids 1000 mg/day plus piperine or placebo for 8 weeks, on standard care. LDL, non-HDL, total cholesterol, triglycerides and lipoprotein(a) fell versus placebo; HDL rose. Small dense LDL did not separate.
- Study in people2014Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study
A high-absorption curcumin form eased knee pain in a short study. 50 adults with knee arthritis took 180 mg a day, or a dummy pill, for 8 weeks. Pain scores were lower on the curcumin form, except in people who started with almost no pain. They also needed less of the pain drug celecoxib. Eight weeks is short, and this is one form.
50 adults with Kellgren-Lawrence grade II or III knee osteoarthritis randomised to Theracurmin 180 mg/day curcumin or placebo for 8 weeks. Knee pain VAS was lower on Theracurmin except in those with baseline VAS of 0.15 or less. Celecoxib use was lower. No major side effects reported.
- Review of studies2024Curcumin on human health: a comprehensive systematic review and meta-analysis of 103 randomized controlled trials
This review pooled 103 studies in 7,216 people and looked at 42 health measures. 23 of the 42 showed a real change. Only four had high-certainty evidence: fasting blood sugar, CRP (a swelling marker), HDL (good) cholesterol and weight. The authors said the quality of the studies was a weakness.
103 randomised trials, 7,216 participants, 42 outcomes. 23 of 42 outcomes were statistically significant. Certainty was rated high for only four: fasting blood sugar, C-reactive protein, HDL and weight. Ten outcomes were moderate, 14 low and 14 very low. The authors note limitations in the methodological quality of the included studies.
- Review of studies2023Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials
Across 66 studies, curcumin or turmeric lowered swelling markers in the blood. CRP fell 0.58 mg/L. TNF-alpha and IL-6 fell too. IL-1 beta did not change. Antioxidant markers improved.
66 randomised trials. CRP down 0.58 mg/L (95% CI minus 0.74 to minus 0.41), TNF-alpha down 3.48 pg/mL and IL-6 down 1.31 pg/mL. IL-1 beta was unchanged at minus 0.46 pg/mL (95% CI minus 1.18 to 0.27). Antioxidant markers improved.
- Review of studies2023Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis
This review pooled studies of curcumin in rheumatoid arthritis. It is the closest this research gets to how people feel and how active the disease is, rather than a blood marker.
The closest this literature comes to a clinical rather than biochemical endpoint, in a defined inflammatory disease. Included because it is a symptom and disease-activity analysis rather than a marker analysis.
- Animal study2013Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice
In mice. The US National Institute on Aging fed curcumin to mice for life, starting at 4 months old. It did not make male or female mice live longer at the dose tested.
NIA Interventions Testing Program. Lifelong curcumin from 4 months of age did not extend lifespan in male or female genetically heterogeneous mice at the concentration tested.
Where to buy Curcumin
2 sellers list Curcumin in our latest read. They are ranked by trust score, then by archive rating, then by certificate tier, then by the lowest price per milligram. Archive evidence is counted before source-backed. Each path is out of 4, and the two are not added. A higher price does not raise the score. The letter is the certificate chip. 0 of them have a published certificate that names Curcumin.
Some seller links may pay this site when you buy through them. A payment never changes a seller's tier or rank, and no seller has a say in any page.
| Seller | Trust score | Vial sizes | From, per mg | Certificate for Curcumin | Seller link |
|---|---|---|---|---|---|
| Molecular Edge Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 600 mg | $0.500 | None found for Curcumin | View |
| Paramount Peptides | 33 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 600 mg | $0.227 | None found for Curcumin | View |
- LC Lab-confirmed: the issuing laboratory echoed this certificate back
- A Current certificate, independent laboratory named, laboratory not yet checked
- B Certificate published, but no laboratory link, older than a year, or the laboratory did not recognise the published lookup
- C No certificate could be read
Every listing and vial size for Curcumin · How the trust score is counted
Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Common questions
Has Curcumin been tested in people?
Yes. 195 people given it across 3 completed trials cited here, 0 of which found nothing. Across 103 studies and 42 health measures, only four had high-certainty evidence, including CRP, a blood marker of swelling. Curcumin barely gets into the blood, so the results belong to special high-absorption forms, not to turmeric.
What is the Curcumin dosage?
No human dose established. Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose. 3 completed trials, 195 people given it
Is Curcumin FDA-approved?
Sold as a dietary supplement, and turmeric is generally recognised as safe as a food. Not approved to treat any condition.
Is turmeric the same as curcumin?
No, and the difference is big enough to matter. Turmeric root is only about 2 to 5% curcuminoids, and curcumin on its own absorbs poorly. Studies use special high-absorption forms, with piperine, fat-bound phytosomes or tiny particles. They do that because plain curcumin barely reaches the blood.
Does it actually reduce inflammation?
It lowers swelling markers in the blood, reliably. Across 66 studies, CRP fell by 0.58 mg/L. TNF-alpha and IL-6 also fell, and IL-1 beta did not change. Whether that prevents any disease is a separate question. No study has answered it.
Which formulation should I use?
One that a study used. Absorption is the bottleneck, and each form gives different blood levels. So results do not carry over freely from one product to another. Matching your product to the study is not fussiness here. It is the whole thing.
Is it safe?
At supplement doses, mostly yes. Stomach upset is the common complaint. Rare liver injury has been reported with high-dose, high-absorption products. Making a compound absorb better also makes its risks absorb better.
Latest reading on Curcumin
Blog posts about Curcumin, newest first.